FDA Extends Review for Lipocine's TLANDO; Advisory Committee Meeting Date of January 10, 2018 Rem… Post author:Sam Post published:November 16, 2017 Post category:BioPharma The FDA has assigned a new Prescription Drug User Fee Act goal date of May 8, 2018. Source: BioSpace You Might Also Like BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… January 4, 2018 MediWound Announces Changes To Its Board Of Directors May 17, 2017 Massachusetts Selecta Biosciences' CEO to Retire at the End of 2018 January 1, 2018
BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… January 4, 2018
